Bulletin 242. Antiepileptic drugs: Appropriate switching to generics or brand equivalents

This is an updated bulletin which includes new information on patient factors to consider before switching antiepileptic drugs, updated cost comparison charts and switch savings, new safety warnings for sodium valproate, pregabalin updated controlled drug scheduling and use of generic pregabalin for all indications.

Tools such as a data pack and GP clinical system searches are provided to support organisations considering a generic switch for appropriate antiepileptic drugs.